Cleveland BioLabs (CBLI), Incuron Receive FDA Approval for CBL0137 IND
Tweet Send to a Friend
Cleveland BioLabs, Inc. (Nasdaq: CBLI) and Incuron, LLC, a joint venture between the Company and Bioprocess Capital Ventures, announced the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE